Chabiotech Co.,Ltd.
085660.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$758.52B
Close$
Share Statistics
| Market cap | $758.52 Billion |
|---|---|
| Enterprise Value | $1.28 Trillion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1636.98 |
| Beta | 0.55 |
| Outstanding Shares | 92,501,000 |
Return
| Return on Equity | 3.43% |
|---|---|
| Return on Assets | 0.50% |
| Return on Invested Capital | -3.55% |
Valuation & Multiples
| P/E Ratio | 89.24 |
|---|---|
| PEG | -59.47 |
| Price to Sales | 0.54 |
| Price to Book Ratio | 0.69 |
| Enterprise Value to Revenue | 0.98 |
| Enterprise Value to EBIT | -20.42 |
| Enterprise Value to Net Income | 89 |
| Total Debt to Enterprise | 0.64 |
| Debt to Equity | 1.99 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Chabiotech Co.,Ltd.
354 employees
CEO: Gyu-Beom Han Chabiotech Co.,Ltd. is a global biotechnology firm specializing in the development of cell and gene therapies, particularly those involving stem and immune cells, with operations in South Korea and internationally. The company's comprehe...